Collagen does more for your body than just improve your skin. Here are the benefits and things to consider before trying.

Why Gen Z should wait to get Botox. People get Botox, or botulinum toxin, injected for a variety of reasons, including to smooth wrinkles and treat migraines. Though Botox has bec ...

Reports of GLP-1RA–associated acute kidney injury (AKI) have emerged, but the risk of GLP-1RA–associated AKI among patients on anti-cancer drugs is unclear. Surprisingly, new research suggests ...

Oct. 24, 2024 (GLOBE NEWSWIRE) -- BioAge Labs (Nasdaq: BIOA) (“BioAge”), a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic ...

BioAge is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. BioAge’s lead ...

In mid-2024, BioAge initiated a Phase 2 trial of azelaprag in combination with tirzepatide for the treatment of obesity ... address key pathways in metabolic aging.

(“BioAge”), a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging, today announced that Kristen ...

Oct. 24, 2024 (GLOBE NEWSWIRE) -- BioAge ... treatment of diseases driven by neuroinflammation. BioAge’s preclinical programs, based on novel insights from the company’s discovery platform built on ...

On Monday, Morgan Stanley (NYSE:MS) initiated coverage on BioAge Labs Inc (NASDAQ:BIOA), assigning the stock an Overweight rating and setting a price target of $40.00. The new rating reflects the ...

The firm highlighted BioAge's focus on developing treatments for metabolic diseases, particularly noting the potential of its leading drug candidate, azelaprag. Azelaprag, an oral small molecule ...